These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8394597)

  • 1. Bombesin receptor antagonists: different classes and cellular basis of action.
    Jensen RT; Mrozinski JE; Coy DH
    Recent Results Cancer Res; 1993; 129():87-113. PubMed ID: 8394597
    [No Abstract]   [Full Text] [Related]  

  • 2. Design and synthesis of bombesin/gastrin-releasing peptide antagonists.
    Best JR; Camble R; Cotton R; Dutta AS; Fleming B; Garner A; Gormley JJ; Hayward CF; McLachlan PF; Scholes PB
    Biochem Soc Trans; 1990 Dec; 18(6):1294-6. PubMed ID: 1708344
    [No Abstract]   [Full Text] [Related]  

  • 3. N-isobutyryl-His-Trp-Ala-Val-D-Ala-His-Leu-NHMe (ICI 216140) a potent in vivo antaconist analogue of bombesin/gastrin releasing peptide (BN/GRP) derived from the C-terminal sequence lacking the final methionine residue.
    Camble R; Cotton R; Dutta AS; Garner A; Hayward CF; Moore VE; Scholes PB
    Life Sci; 1989; 45(17):1521-7. PubMed ID: 2555638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bombesin receptor antagonists differentiate receptor subtypes in rat brain.
    Ladenheim EE; Jensen RT; Mantey SA; Taylor JE; Coy DH; Moran TH
    Eur J Pharmacol; 1993 Apr; 235(1):121-5. PubMed ID: 8390937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in the development of potent bombesin receptor antagonists.
    Jensen RT; Coy DH
    Trends Pharmacol Sci; 1991 Jan; 12(1):13-9. PubMed ID: 1706545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antagonism of bombesin in the CNS by substance P analogues.
    Yachnis AT; Crawley JN; Jensen RT; McGrane MM; Moody TW
    Life Sci; 1984 Nov; 35(19):1963-9. PubMed ID: 6208451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of novel bombesin receptor antagonists on pancreatic secretion in rats.
    Jaworek J; Konturek PK; Konturek SJ; Cai RZ; Schally AV
    Eur J Pharmacol; 1992 Apr; 214(2-3):239-45. PubMed ID: 1381317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
    Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
    Lin JT; Coy DH; Mantey SA; Jensen RT
    J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic stability and tumor inhibition of bombesin/GRP receptor antagonists.
    Davis TP; Crowell S; Taylor J; Clark DL; Coy D; Staley J; Moody TW
    Peptides; 1992; 13(2):401-7. PubMed ID: 1329046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bombesin-like peptides: of ligands and receptors.
    Spindel ER; Giladi E; Segerson TP; Nagalla S
    Recent Prog Horm Res; 1993; 48():365-91. PubMed ID: 8382830
    [No Abstract]   [Full Text] [Related]  

  • 12. Different receptors mediate the action of bombesin-related peptides on gastric smooth muscle cells.
    Severi C; Jensen RT; Erspamer V; D'Arpino L; Coy DH; Torsoli A; Delle Fave G
    Am J Physiol; 1991 May; 260(5 Pt 1):G683-90. PubMed ID: 1852115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters.
    Szepeshazi K; Schally AV; Groot K; Halmos G
    Int J Cancer; 1993 May; 54(2):282-9. PubMed ID: 8387464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Localization and physiologic role of neuropeptides and their receptors--peptides of the bombesin family--GRP, neuromedin B and neuromedin C].
    Namba M; Tajima K; Kono N; Tarui S
    Nihon Rinsho; 1990 May; 48(5):969-74. PubMed ID: 1973960
    [No Abstract]   [Full Text] [Related]  

  • 15. Bombesin antagonists: experimental and clinical results.
    Schütte J; Seeber S
    Recent Results Cancer Res; 1993; 129():115-29. PubMed ID: 7688906
    [No Abstract]   [Full Text] [Related]  

  • 16. Antagonists of bombesin/gastrin releasing peptide based on [D-Ala24]GRP(20-26)-heptapeptide. Modifications leading to potent analogues with prolonged duration of action.
    Best JR; Cotton R; Dutta AS; Fleming B; Garner A; Gormley JJ; Hayward CF; McLachlan PF; Scholes PB
    Drug Des Deliv; 1990 Oct; 6(4):255-71. PubMed ID: 1707276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease.
    Sunday ME; Kaplan LM; Motoyama E; Chin WW; Spindel ER
    Lab Invest; 1988 Jul; 59(1):5-24. PubMed ID: 2839735
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular genetic analysis of two distinct receptors for mammalian bombesin-like peptides.
    Battey J; Wada E; Corjay M; Way J; Fathi Z; Shapira H; Harkins R; Wu J; Slattery T; Mann E
    J Natl Cancer Inst Monogr; 1992; (13):141-4. PubMed ID: 1327030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a potent bombesin receptor antagonist with prolonged in vivo inhibitory activity on bombesin-stimulated amylase and protein release in the rat.
    Coy DH; Mungan Z; Rossowski WJ; Cheng BL; Lin JT; Mrozinski JE; Jensen RT
    Peptides; 1992; 13(4):775-81. PubMed ID: 1279632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
    Narayan S; Spindel ER; Rubin NH; Singh P
    Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.